Skip to main content
SpringerLink
Log in

How do pharmacists respond to complaints of acute insomnia? A simulated patient study

  • Research Article
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

Objective It is known that many people with insomnia choose to self medicate and present at community pharmacies, particularly in cases of acute insomnia. The objective of this study is to investigate how community pharmacists respond to complaints of acute insomnia from people who seek self treatment and determine the factors affecting this response. Setting Community pharmacies in New South Wales, Australia. Method A simulated patient study was conducted in 100 randomly selected pharmacies located in Newcastle and Sydney, Australia. A standardized scenario of acute sleep onset insomnia and a scoring system was used in each pharmacy. Main outcome measures Main outcome measures included supply/non supply of an over the counter sleep aid to the simulated patient, and scores for pharmacists for skills in eliciting information prior to supply of medication (Pre Supply Score), counseling about medication (Supply Score), or about sleep (Sleep Score). Results Of the 100 pharmacies, upon simulated patient presentation, 96% supplied a product, the remaining 4% referred to a physician. Non-pharmacological advice was provided in 42%. Pharmacists scored highly on advice provided with supply of a medication (Supply scores/4, 3.1 ± 0.9), but lower on skills in eliciting information prior to supply (Pre-supply score/8, 3.6 ± 1.9) and sleep related counselling (Sleep Score/9, 2.1 ± 1.7). Lower estimated pharmacist age, being in a chain type pharmacy, and having a visible symbol of quality accreditation were found to significantly improve (P < 0.05 the Sleep Score outcome. Lower estimated pharmacist age as also significantly associated with higher Supply Score (P < 0.05); whilst both lower estimated age an visible quality assurance signage were associated with higher Pre-Supply scores (P < 0.05). Conclusion The results of this study suggest that many pharmacists are responding appropriately to complaints of sleeplessness in terms of eliciting insomnia type and counseling about medicines use. However more education for pharmacists would help to further promote good sleep health, and address behaviors including reliance on medicines taking that can progressively worsen insomnia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Bhat A, Shafi F, Solh A. Pharmacotherapy of insomnia. Expert Opin Pharmacother. 2008;9(3):351–62.

    Article  PubMed  CAS  Google Scholar 

  2. Buysse DJ, Angst J, Gamma A, Ajdacic V, Eich D, Rössler W. Prevalence, course, and comorbidity of insomnia and depression in young adults. Sleep. 2008;31(4):473–80.

    PubMed  Google Scholar 

  3. Passarella S, Duong MT. Diagnosis and treatment of insomnia. Am J Health Syst Pharm. 2008;65(10):927–34.

    Article  PubMed  CAS  Google Scholar 

  4. Roth T, Roehrs T, Pies R. Insomnia: pathophysiology and implications for treatment. Sleep Med Rev. 2007;11(1):71–9.

    Article  PubMed  Google Scholar 

  5. Sivertsen B, Krokstad S, Mykletun A, Overland S. Insomnia symptoms and use of health care services and medications: the HUNT-2 study. Behav Sleep Med. 2009;7(4):210–22.

    Article  PubMed  Google Scholar 

  6. Morin CM, LeBlanc M, Daley M, Grégoire JP, Mérette C. Epidemiology of insomnia: prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors. Sleep Med. 2006;7(2):123–30.

    Article  PubMed  CAS  Google Scholar 

  7. Taylor DJ, Lichstein KL, Durrence H, Riedel BW, Bush AJ. Epidemiology of insomnia, depression, and anxiety. Sleep. 2005;28(11):1457–64.

    PubMed  Google Scholar 

  8. Breslau N, Roth T, Rosenthal L, Andreski P. Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol Psychiatry. 1996;39(6):411–8.

    Article  PubMed  CAS  Google Scholar 

  9. Sivertsen B, Overland S, Neckelmann D, et al. The long-term effect of insomnia on work disability: the HUNT-2 historical cohort study. Am J Epidemiol. 2006;163(11):1018–24.

    Article  PubMed  Google Scholar 

  10. Daley M, Morin CM, LeBlanc M, Grégoire JP, Savard J, Baillargeon L. Insomnia and its relationship to health-care utilization, work absenteeism, productivity, and accidents Sleep Med. doi:10.1016/j.sleep.2008.04.005.

  11. Bartlett DJ, Marshall NS, Williams A, Grunstein RR. Predictors of primary medical care consultation for sleep disorders. Sleep Med. 2008;9(8):857–64.

    Article  PubMed  Google Scholar 

  12. Bartlett DJ, Marshall NS, Williams A, Grunstein RR. Sleep health New South Wales: chronic sleep restriction and daytime sleepiness. Intern Med J. 2008;38(1):24–31.

    PubMed  CAS  Google Scholar 

  13. Drake CL, Roehrs T, Roth T. Insomnia causes, consequences, and therapeutics: an overview. Depress Anxiety. 2003;18(4):163–76.

    Article  PubMed  Google Scholar 

  14. Buysse DJ. Chronic insomnia. Am J Psychiatry. 2008;165(6):678–86.

    Article  PubMed  Google Scholar 

  15. Richardson GS, Roehrs TA, Rosenthal L, Koshorek G, Roth T. Tolerance to daytime sedative effects of H1 antihistamines. J Clin Psychopharmacol. 2002;22(5):511–5.

    Article  PubMed  CAS  Google Scholar 

  16. Leybishkis B, Fasseas P, Ryan K. Doxylamine overdose as a potential cause of rhabdomyolysis. Am J Med Science. 2001;322(1):48–9.

    Article  CAS  Google Scholar 

  17. Thomas A, Nallur DG, Jones N, Deslandes PN. Diphenhydramine abuse and detoxification: a brief review and case report. J Psychopharmacol. 2009;23(1):101–5.

    Article  PubMed  CAS  Google Scholar 

  18. Benrimoj SI, Werner JB, Raffaele C, et al. A system for monitoring quality standards in the provision of non-prescription medicines from Australian community pharmacies. Pharm World Sci. 2008;30(2):147–53.

    Article  PubMed  Google Scholar 

  19. Black J, Saini B, Wong K. The role of pharmacists in improving the management of sleep disorders in the community. Respirology. 2007;12(1):A24.

    Google Scholar 

  20. Tze-Min Ang K, Saini B, Wong K. Sleep health awareness in pharmacy undergraduates and practicing community pharmacists. J Clin Pharm Ther. 2008;33:641–52.

    Article  PubMed  CAS  Google Scholar 

  21. Benrimoj SI, Gilbert A, Quintrell N, de Almeida Neto A. Non-prescription medicines: a process for standards development and testing in community pharmacies. Pharm World Sci. 2007;29:386–94.

    Article  PubMed  Google Scholar 

  22. Schneider C, Everett W, Geelhoed E, Kendall P, Clifford R. Measuring the assessment and counseling provided with the supply of nonprescription asthma reliever medication: a simulated patient study. Ann Pharmacother. 2009;43:1512–8.

    Article  PubMed  Google Scholar 

  23. Puumalainen II, Peura SH, Kansanaho HM, Benrimoj SI, Airaksinen M. Progress in patient counselling practices in Finnish community pharmacies. Int J Pharm Prac. 2005;13:149–56.

    Article  Google Scholar 

  24. Berger K, Eickhoff C, Schulz M. Counselling quality in community pharmacies: implementation of the pseudo customer methodology in Germany. J Clin Pharm Ther. 2005;30:45–57.

    Article  PubMed  CAS  Google Scholar 

  25. Granas AG, Haugli A, Horn AM. Smoking cessation advice provided in 53 Norwegian pharmacies. Int J Pharm Pract. 2004;12(4):179–84.

    Article  Google Scholar 

  26. Sigrist T, Benrimoj SI, Hersberger K, Langford J. Changing pharmacists’ and pharmacist assistants’ practice in dealing with direct requests for analgesics. Int J Pharm Pract. 2002;10:23–9.

    Article  Google Scholar 

  27. Chua SS, Ramachandran CD, Paraidathathu TT. Response of community pharmacists to the presentation of back pain: a simulated patient study. Int J Pharm Pract. 2006;14:171–8.

    Article  Google Scholar 

  28. Watson MC, Hart J, Johnston M, et al. Exploring the supply of non-prescription medicines from community pharmacies in Scotland. Pharm World Sci. 2008;30(5):526–35.

    Article  PubMed  Google Scholar 

  29. Norris PT. Purchasing restricted medicines in New Zealand pharmacies: results from a “mystery shopper” study. Pharm World Sci. 2002;24(4):149–53.

    Article  Google Scholar 

  30. Pharmaceutical Society of Australia. Standards for the provision of pharmacy medicines and pharmacist only medicines in community pharmacy. Canberra: The Society, 2010.

  31. Morgan M, Jenkins L, Risdale L. Patient pressure for referral for headache: a qualitative study of GPs referral behavior. Br J Gen Prac. 2007;57:29–35.

    Google Scholar 

  32. Charles J, Harrison C, Britt H. Insomnia. Aust Fam Physician. 2009;38(5):283.

    PubMed  Google Scholar 

  33. Smith L, Bosnic-Anticevich S, Mitchell B, Krass I, Saini B, Armour C. Treating asthma with a self-management model of illness behavior in an Australian community pharmacy setting. Soc Sci Med. 2007;64:1501–11.

    Article  PubMed  Google Scholar 

  34. O’Connor J, Seeto C, Saini B, et al. Healthcare professional versus patient goal setting in intermittent allergic rhinitis. Pat Educ Couns. 2008;70:111–7.

    Article  Google Scholar 

  35. Espie C, MacMahon K, Kelly H. Randomized clinical effectiveness trial of nurse-administered small-group cognitive behavioral therapy for persistent insomnia in general practice. Sleep. 2007;30:574–84.

    PubMed  Google Scholar 

  36. Alte D, Weitschies W, Ritter C. Evaluation of consultation in community pharmacies with mystery shoppers. Ann Pharmacother. 2007;41:1023–30.

    Article  PubMed  Google Scholar 

  37. Svarstad B, Bultman D, Mount J. Patient counseling provided in community pharmacies: effects of state regulation, pharmacist age and busyness. J Am Pharm Assoc. 2004;44(1):22–5.

    Article  Google Scholar 

Download references

Acknowledgments

The author would like to acknowledge Penelope Redman, Grace Shoukry and Kaye Kippist for their assistance in conducting data collection.

Funding

None declared. The project reported in this paper did not receive any financial assistance from any sources; and was conducted as part of a BPharmacy final year undergraduate honors project.

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. Faculty of Pharmacy, University of Sydney, Pharmacy Building (A15), Sydney, NSW, 2006, Australia

    Carly Kippist & Bandana Saini

  2. Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia

    Keith Wong & Delwyn Bartlett

  3. Department of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Sydney, Australia

    Keith Wong & Delwyn Bartlett

  4. Centre for Integrated Research into the Understanding of Sleep, NHMRC funded Centre of Clinical and Research Excellence, University of Sydney, Sydney, Australia

    Keith Wong, Delwyn Bartlett & Bandana Saini

Authors
  1. Carly Kippist
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Keith Wong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Delwyn Bartlett
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bandana Saini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bandana Saini.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kippist, C., Wong, K., Bartlett, D. et al. How do pharmacists respond to complaints of acute insomnia? A simulated patient study. Int J Clin Pharm 33, 237–245 (2011). https://doi.org/10.1007/s11096-011-9482-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-011-9482-5

Keywords

Search

Navigation